Scholar Rock SRRK Q1 2026 Earnings Prerevenue Biotech Misses Estimates as Clinical Pipeline Progress Remains in Focus LQR House YHC Stock Analysis 383 Loss Key Levels 20260521 WOK Plunges 15 to 016 Testing Critical Support Levels Exodus Movement EXOD Q1 2026 Results Miss Estimates EPS 108 vs 022